Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas is participating in a health reform panel discussion for the Capitolbeat Annual Conference in Indianapolis, IN
News | 08. 21. 2009
